Font Size: a A A
Keyword [mCRC]
Result: 1 - 13 | Page: 1 of 1
1. Comparison Of Efficacy And Adverse Events Between Bevacizumab And Anti-EGFR Monoclonal Antibody In The Treatment For Metastatic Colorectal Cancer
2. Early Response Evaluation Of Anti-angiogenesis Therapy In Metastatic Colorectal Cancer By Contrast Enhanced Ultrasound
3. Efficacy Of First-line Treatment Of Chemotherapy And Chemotherapy Plus Targeting Agents For MCRC
4. Baseline Carcinoembryonic Antigen(CEA) Serum Levels Predict Cetuximab-based Treatment Response In Metastatic Colorectal Cancer And The Mechanism Study
5. Consistency Analysis Of RAS/BRAF Gene Mutation In Plasma CtDNA And Tumor Tissue Samples In Advanced Colorectal Cancer And Its Value In Predicting The Efficacy Of EGFR Monoclonal Antibody
6. CT Enhancement Value Correlated With The Curative Effect Of Bevacizumab In Combination With Chemotherapy For Metastatic Colorectal Cancer
7. Treatment patterns and cost-effectiveness of therapeutic sequences among advanced colorectal cancer patients
8. Survival Analysis And Prognostic Factors Of Palliative Radiotherapy In Patients With Metastatic Colorectal Cancer
9. Analysis Of The Association Of NOTCH3 Mutation With The Prognosis Of MCRC Patients Treated With Immune Checkpoint Inhibitors
10. Real World Study On The Efficacy And Safety Of Stereotactic Radiotherapy For Liver And Lung Metastasis Of Colorectal Cancer
11. The Role OfTRIM21-regulated Hippo-YAP Signaling In The Invasion And Metastasis Of Colorectal Cancer
12. Prognostic Significance Of The Platelet-to-lymphocyte Ratio In Patients With Unresectable Metastatic Colorectal Cancer
13. Effects Of MiR-1266 On The Proliferation,Migration And Invasion Of Colorectal Cancer Cells
  <<First  <Prev  Next>  Last>>  Jump to